CEO Salary & Executive Compensation
IDEXX Laboratories IDXX
CEO: Jay Mazelsky · Diagnostics · 11,300 employees
Jay Mazelsky, CEO of IDEXX Laboratories (IDXX), earned $8.0M in total compensation in 2025. IDEXX Laboratories receives a Pay-for-Performance grade of B (70/100), with a CEO-to-worker pay ratio of 89:1 and a say-on-pay shareholder approval of 93.2%. The company's 3-year total shareholder return is +2.8%.
How IDEXX Laboratories CEO Pay Compares
Jay Mazelsky's $8.0M total compensation is 0% below the Diagnostics industry median of $8.0M. The 89:1 CEO-to-worker pay ratio is 0% lower than the industry average of 89:1.
Total compensation for Jay Mazelsky at IDEXX Laboratories (IDXX) was $8.0M. Mid-cap public-company CEO packages tend to track this pattern — equity-heavy, multi-year vesting, performance-tied.
The CEO-to-median-worker pay ratio runs 89x. Lower ratios typically reflect companies with higher-paid workforces (financial services, technology, professional services) where the median worker pay denominator is itself substantial. Performance has been muted across the three-year window: 2.8% TSR, 8.4% revenue change. Stagnant performance combined with substantial CEO pay is the classic setup for proxy-advisor opposition on say-on-pay votes.
Say-on-pay support was strong at 93%. The Dodd-Frank-mandated advisory vote on executive compensation passes at most U.S. public companies with comfortable margins; meaningful dissent typically requires either pay-performance misalignment or specific governance concerns. IDEXX Laboratories operates in Diagnostics with 11,300 employees and $3.9B in annual revenue, and currently carries a market capitalization of $40.0B. Pay comparisons across companies require controlling for these structural factors — a $20M package at a $10B-revenue tech company reads differently than the same package at a $1B-revenue industrial.
Source: SEC EDGAR — DEF 14A proxy statements for IDEXX Laboratories (IDXX).
Compensation Breakdown
Jay Mazelsky's $8.0M total compensation package for fiscal year 2025 includes $800K in base salary, $4.0M in stock awards, $960K in option awards, and $1.2M in bonus and non-equity incentives.
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
| 2024 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
| 2023 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
| 2022 | $800K | - | $4.0M | $960K | $1.2M | $880K | $8.0M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Jay Mazelsky, CEO of IDEXX Laboratories (IDXX), earns $8.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Frequently Asked Questions
Jay Mazelsky, CEO of IDEXX Laboratories (IDXX), earns $8.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
IDEXX Laboratories has a Pay-for-Performance Score of B (70/100). The company's 3-year total shareholder return is +2.8%, and the say-on-pay shareholder vote passed with 93.2% approval.
The CEO-to-median-worker pay ratio at IDEXX Laboratories is 89:1. The median worker at IDEXX Laboratories earns $90K per year, while CEO Jay Mazelsky earns $8.0M in total compensation.
IDEXX Laboratories employs approximately 11,300 people. The company operates in the Diagnostics industry within the Healthcare sector, generating $3.9B in annual revenue.